Nanobiotix annual capital expenditures (capex)
2018
2019
2020
2021
2022
2023
2024
2025
Nanobiotix Capital Expenditures (CapEx) Growth & History (NANO)
Nanobiotix's capital expenditures (capex) was €538,000 for fiscal 2025.
View full Nanobiotix company overviewNanobiotix annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €538,000 | −€308,000 | −36.41% |
| 2024 | 2024-12-31 | €846,000 | €518,000 | +157.93% |
| 2023 | 2023-12-31 | €328,000 | €236,000 | +256.52% |
| 2022 | 2022-12-31 | €92,000 | −€136,000 | −59.65% |
| 2021 | 2021-12-31 | €228,000 | €132,000 | +137.50% |
| 2020 | 2020-12-31 | €96,000 | −€995,000 | −91.20% |
| 2019 | 2019-12-31 | €1.1M | €675,000 | +162.26% |
| 2018 | 2018-12-31 | €416,000 | — | — |
Nanobiotix capital expenditures (capex) trends
Over the last five fiscal years, Nanobiotix's capital expenditures (capex) increased from €96,000 to €538,000, a change of €442,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nanobiotix source filings ↗